MKI67 and uterine cervix neoplasm: In summary, the HPV test may be superior to stratify the long-term risk of cervical neoplasms, while the p16/Ki67 test may be particularly strong in predicting an immediate outcome; moreover, the p16/Ki67 test could allow longer intervals in HPV-positive women but who are negative at the triage test.